CENTER ID: | BobuA.00658.a |
ORGANISM: | Borrelia burgdorferi B31 |
ASSOCIATED DISEASE: | Lyme disease |
CURRENT STATUS: | in PDB |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
I |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
BobuA.00658.a.A1.GE26276 | Full length( BobuA.00658.a ) | 1 | 80 | ||
BobuA.00658.a.A11.GE44027 | Full length( BobuA.00658.a ) | 1 | 80 | ||
BobuA.00658.a.A12.GE44081 | Full length( BobuA.00658.a ) | 1 | 80 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
BobuA.00658.a.A1.PS00211 | Full length( BobuA.00658.a ) | 1 | 80 | ||
BobuA.00658.a.A1.PS00348 | Full length( BobuA.00658.a ) | 1 | 80 | ||
BobuA.00658.a.A11.PS38662 | Full length( BobuA.00658.a ) | 1 | 80 |
RESOURCE | REFERENCE ID |
---|---|
OrthoMCL: | OG5_127028 |
PATRIC ID: | fig|224326.49.peg.1095 |
RefSeq: | NP_212838.1 |
UniProt: | O51647 |
HARVESTED ON: | 3/2/2009 |
SEQUENCED ON: | 3/21/2012 |
EXPECTED MW: | 11kDa |
OBSERVED MW: | 12kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass with incomplete coverage |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 98 |
HARVESTED ON: | 12/17/2020 |
SEQUENCED ON: | 1/4/2021 |
EXPECTED MW: | 11kDa |
OBSERVED MW: | 11kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | Rosetta2 (DE3) |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
HARVESTED ON: | 3/18/2021 |
SEQUENCED ON: | 1/14/2021 |
EXPECTED MW: | 11kDa |
OBSERVED MW: | 13kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | Rosetta2 (DE3) |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
PURIFICATION DATe: | 4/17/2009 |
CONCENTRATION: | 20.4mg/ml |
OBSERVED MW: | data unavailable |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 22 |
VIAL VOLUME: | 100µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 98 |
PURIFICATION DATe: | 9/11/2009 |
CONCENTRATION: | 20.16mg/ml |
OBSERVED MW: | data unavailable |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 7 |
VIAL VOLUME: | data unavailable |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 98 |
PURIFICATION DATe: | 3/9/2021 |
CONCENTRATION: | 21.63mg/ml |
OBSERVED MW: | 12kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP |
EXPRESSION HOST: | Rosetta2 (DE3) |
VIAL COUNT (approx.): | 9 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |